Show simple item record

dc.contributor.authordo Amaral, Alberto
dc.date2021-11-25T13:36:34.000
dc.date.accessioned2021-11-26T12:31:28Z
dc.date.available2021-11-26T12:31:28Z
dc.date.issued2005-01-01T00:00:00-08:00
dc.identifieryls_sela/47
dc.identifier.contextkey3111443
dc.identifier.urihttp://hdl.handle.net/20.500.13051/17544
dc.description.abstractAccording to the data compiled by the UN Millennium Development Goals Project, 40 million people are infected by the AIDS virus in developing countries, with 26.6 million on the African continent. About 93% of those infected with the AIDS virus cannot afford to buy the anti-retroviral medication which they need (1). The Joint Program of the United Nations on AIDS believed that unequal access to treatment at acceptable prices is one of the main reasons for the low levels of survival in poor nations.
dc.titleCompulsory Licensing and Access to Medicine in Developing Countries
dc.source.journaltitleSELA (Seminario en Latinoamérica de Teoría Constitucional y Política) Papers
refterms.dateFOA2021-11-26T12:31:28Z
dc.identifier.legacycoverpagehttps://digitalcommons.law.yale.edu/yls_sela/47
dc.identifier.legacyfulltexthttps://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1046&context=yls_sela&unstamped=1


Files in this item

Thumbnail
Name:
SELA05_Amaral_DC_Eng_20110711.pdf
Size:
60.06Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record